{"id":"W3006085306","doi":"10.1111/dom.13997","title":"Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; American Diabetes Association","keywords":"Saxagliptin; Medicine; Dapagliflozin; Glimepiride; Metformin; Type 2 diabetes; Pharmacology; Fixed-dose combination; Diabetes mellitus; Internal medicine; Urology; Endocrinology; Sitagliptin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002576098,0.001689641,0.003681535,0.0004528046,0.0003882646,0.001480718,0.0009775884,0.001711533,0.004143882],"category_scores_gemma":[0.001965024,0.0009660513,0.002735154,0.0004162321,0.001105622,0.00121008,0.0005225067,0.003045635,0.0007577752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007534595,"about_ca_system_score_gemma":0.0007141202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005837367,"about_ca_topic_score_gemma":0.001237228,"domain_scores_codex":[0.9988357,0.0005656231,0.0001246659,0.0002423787,0.0001063275,0.0001252531],"domain_scores_gemma":[0.9982818,0.000428849,0.0004974927,0.0001671625,0.00009712268,0.0005276137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.981926,0.00486483,0.001217053,0.0002522543,0.001137252,0.00002089188,0.00002968092,0.0001620983,0.002640672,0.00001756446,0.000169202,0.007562515],"study_design_scores_gemma":[0.9072326,0.085949,0.004629174,0.00002423368,0.001005034,0.00003492712,0.0000189914,0.0003966324,0.0004978841,0.00003806593,0.0001576584,0.00001580271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966906,0.001694753,0.0001706349,0.0001884736,0.0001268116,0.0003802117,0.0002850631,0.00002909649,0.000434428],"genre_scores_gemma":[0.9961021,0.000933736,0.0004945669,0.0003836162,0.0003049302,0.0005486372,0.0005987702,0.00001098748,0.0006226914],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004143882,"threshold_uncertainty_score":0.01386273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01450528825502282,"score_gpt":0.22342156750598,"score_spread":0.2089162792509572,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}